Neurobiology of Aging
Volume 30, Issue 6 , Pages 910-919 , June 2009

Oxidative damage and sensitivity to nociceptive stimulus and opioids in aging rats

  • Atul Raut

      Affiliations

    • Department of Pharmacology and Neuroscience, University of North Texas Health Science Center, 3500 Camp Bowie Blvd, Fort Worth, TX 76107, USA
  • ,
  • Anna Ratka

      Affiliations

    • Department of Pharmaceutical Sciences, Irma Lerma Rangel College of Pharmacy, Texas A&M Health Science Center, 1010 West Avenue B, MSC 131, Kingsville, TX 78363-8202, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 361 593 4271; fax: +1 361 593 4303.

Received 1 August 2007 ,Revised 24 September 2007 ,Accepted 28 September 2007.

References 

  1. Basbaum AI, Jessell TM. The perception of pain. In:  Kandel ER,  Schwartz JH,  Jessell TM editor. Principles of Neural Science. New York: McGraw Hill; 2000;p. 472–490
  2. Chan SH, Lai YY. Effects of aging on pain responses and analgesic efficacy of morphine and clonidine in rats. Exp. Neurol. 1982;75:112–119
  3. Cook CD, Barrett AC, Roach EL, Bowman JR, Picker MJ. Sex-related differences in the antinociceptive effects of opioids: importance of rat genotype, nociceptive stimulus intensity, and efficacy at the mu opioid receptor. Psychopharmacol. 2000;150:430–442
  4. Craft RM, Henley SR, Haaseth RC, Hruby VJ, Porreca F. Opioid antinociception in a rat model of visceral pain: systemic versus local drug administration. J. Pharmacol. Exp. Ther. 1995;275:1535–1542
  5. Crisp T, Minus TO, Coleman ML, Giles JR, Cibula C, Finnerty EP. Aging, peripheral nerve injury and nociception: Effects of the antioxidant 16-desmethyltirilazad. Behav. Brain Res. 2006;166:159–165
  6. Delfs JM, Kong H, Mestek A, Chen Y, Yu L, Reisine T, et al. Expression of mu opioid receptor mRNA in rat brain: an in-situ hybridization study at the single cell level. J. Comp. Neurol. 1994;345:46–68
  7. Dennis SG, Melzack R, Gutman S, Boucher F. Pain modulation by adrenergic agents and morphine as measured by three pain tests. Life Sci. 1980;26:1247–1259
  8. Dubey A, Forster MJ, Lal H, Sohal RS. Effect of age and caloric intake on protein oxidation in different brain regions and on behavioral functions of the mouse. Arch. Biochem. Biophys. 1996;333:189–197
  9. Farr SA, Poon HF, Dogrukol-Ak D, Drake J, Banks WA, Eyerman E, et al. The antioxidants alpha-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice. J. Neurochem. 2003;84:1173–1183
  10. Floyd RA. Antioxidant, oxidative stress and degenerative neurological disorders. Proc. Soc. Exp. Biol. Med. 1999;222:236–245
  11. Forster MJ, Sohal BH, Sohal RS. Reversible effects of long-term caloric restriction on protein oxidative damage. J. Gerontol. A: Biol. Sci. Med. Sci. 2000;55:B522–B529
  12. Fukagawa NK. Aging: is oxidative stress a marker or is it casual?. Proc. Soc. Exp. Biol. Med. 1999;222:293–298
  13. Gloth F. Concerns with chronic analgesic therapy in elderly patients. Am. J. Med. 1996;101:19S–24S
  14. Hacimuftuoglu A, Handy CR, Goettl VM, Lin CG, Dane S, Stephens RL. Antioxidants attenuate multiple phases of formalin-induced nociceptive response in mice. Behav. Brain Res. 2006;173:211–216
  15. Hoskins B, Burton CK, Ho IK. Differences in morphine-induced antinociception and locomotor activity in mature adult and aged mice. Pharmacol. Biochem. Behav. 1986;25:599–605
  16. Kasapoglu M, Ozben T. Alterations of antioxidant enzymes and oxidative stress markers in aging. Exp. Gerontol. 2001;36:209–220
  17. Kavaliers M, Hirst M, Teskey GC. Aging, opioid analgesia and the pineal gland. Life Sci. 1983;32:2279–2287
  18. Kramer E, Bodnar RJ. Age-related decrements in morphine analgesia: a parametric analysis. Neurobiol. Aging. 1986;7:185–191
  19. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 1990;186:464–478
  20. Liu J, Atamna H, Kuratsune H, Ames BN. Delaying brain mitochondrial decay and aging with mitochondrial antioxidants and metabolites. Ann. NY Acad. Sci. 2002;959:133–166
  21. MacIntyre PE, Jarvis DA. Age is the best predictor of post operative morphine requirements. Pain. 1996;64:357–364
  22. Mansour A, Khachaturian H, Lewis ME, Akil H, Watson SJ. Anatomy of C.N.S. opioid receptors. Trends Neurosci. 1988;11:308–314
  23. Moore AK, Vilderman S, Lubenskyi W, Mc-Cans J, Fox GS. Differences in epidural morphine requirements between elderly and young patients after abdominal surgery. Anesth. Analg. 1990;70:316–320
  24. Navarro A, Boveris A. Rat brain and liver mitochondria develop oxidative stress and lose enzymatic activities on aging. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004;287:R1244–R1249
  25. Navarro A, Sanchez Del Pino MJ, Gomez C, Peralta JL, Boveris A. Behavioral dysfunction, brain oxidative stress, and impaired mitochondrial electron transfer in aging mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2002;282:R985–R992
  26. Nohl H. Involvement of free radicals in ageing: a consequence or cause of senescence. Br. Med. Bull. 1993;49:653–667
  27. Ohkawa H, Ohishi N, Ygi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1979;95:351–358
  28. Page KJ, Besret L, Jain M, Monaghan EM, Dunnett SB, Everitt BJ. Effects of systemic 3-nitropropionic acid-induced lesions of the dorsal striatum on cannabinoid and mu-opioid receptor binding in the basal ganglia. Exp. Brain Res. 2000;130:142–150
  29. Pasternak GW. Pharmacological mechanisms of opioid analgesics. Clin. Neuropharm. 1993;16:1–18
  30. Raut A, Iglewski M, Ratka A. Differential effects of impaired mitochondrial energy production on the function of mu and delta opioid receptors in neuronal SK-N-SH cells. Neurosci. Lett. 2006;14:242–246
  31. Raut A, Rao VR, Ratka A. Changes in opioid receptor proteins during mitochondrial impairment in differentiated SK-N-SH cells. Neurosci. Lett. 2007;422:187–192
  32. Rebrin I, Forster MJ, Sohal RS. Effects of age and caloric intake on glutathione redox state in different brain regions of CG7BL/6 and DA/2 mice. Brain Res. 2007;1127:10–18
  33. Redwine KE, Trujillo KA. Effects of NMDA receptor antagonists on acute mu-opioid analgesia in the rat. Pharmacol. Biochem. Behav. 2003;76:361–372
  34. Saunders DR, Paolino RM, Bousquet WF, Miya TS. Age-related responsiveness of the rat to drugs affecting the central nervous system. Proc. Soc. Exp. Biol. Med. 1974;147:593–595
  35. Smith MA, French AM. Age-related differences in sensitivity to the antinociceptive effects of kappa opioids in adult male rats. Psychopharmacology. 2002;162:255–264
  36. Spratto GR, Dorio RE. Effect of age on acute morphine response in the rat. Res. Commun. Chem. Pathol. Pharmacol. 1978;19:23–36
  37. Tatsumi T, Fliss H. Hypochlorous acid and chloramines increase endothelial permeability: possible involvement of cellular zinc. Am. J. Physiol. 1994;267:H1597–H1607
  38. Vigano A, Bruera E, Suarez-Almazor ME. Age, pain intensity and opioid dose in patients with advanced cancer. Cancer. 1998;83:1244–1250
  39. Walker EA, Tiano MJ, Benyas SI, Dykstra LA, Picker MJ. Naltrexone and beta-funaltrexamine antagonism of the antinociceptive and response rate-decreasing effects of morphine, dezocine, and d-propoxyphene. Psychopharmacology. 1999;144:45–53
  40. Wallace JE, Krauter EE, Campbell BA. Motor and reflexive behavior in the aging rat. J. Gerontol. 1980;35:364–370
  41. Webster GW, Shuster L, Eleftheriou BE. Morphine analgesia in mice of different ages. Exp. Aging Res. 1976;2:221–233
  42. Zastawny RL, George SR, Nguyen T, Cheng R, Tsatsos J, O’Dowd BF. Cloning, characterization and distribution of mu opioid receptors in rat brain. J. Neurochem. 1994;62:2099–2105

PII: S0197-4580(07)00384-3

doi: 10.1016/j.neurobiolaging.2007.09.010

Neurobiology of Aging
Volume 30, Issue 6 , Pages 910-919 , June 2009